XML 31 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Jun. 30, 2012
Stockholders Equity Tables  
Stock Option Plan

Each option represents the right to purchase one share of the Company’s common stock at June 30, 2012:

 

    Total     Shares              
    Shares     Reserved for     Shares     Remaining  
    Reserved     Outstanding     Issued as     Options/Shares  
Name of Plan   Under Plans     Options     Stock Bonus     Under Plans  
                         
Incentive Stock Option Plans     21,100,000       10,668,275       N/A       8,945,225  
Non-Qualified Stock Option Plans     37,760,000       26,804,313       N/A       4,888,738  
Stock Bonus Plans     15,940,000       N/A       8,087,883       7,849,829  
Stock Compensation Plan     13,500,000       N/A       6,386,531       7,113,469  
Stock-Based Compensation Expense

    Nine months Ended June 30,  
    2012     2011  
Employees   $ 1,761,365     $ 1,210,735  
Non-employees   $ 457,497     $ 168,133  

 

    Three months Ended June 30,  
    2012     2011  
Employees   $ 463,314     $ 407,469  
Non-employees   $ 213,789     $ 5,001  

 
Derivative liabilities,warrants and other options

Below is a chart showing the derivative liabilities and the number of warrants outstanding at June 30, 2012:

 

Warrant   Issue Date   Shares Issuable upon Exercise of Warrant     Exercise Price   Expiration Date   Refer-ence  
                         
                         
Series N   8/18/08     5,187,709       0.30   8/18/14     1  
Series A   6/24/09     1,303,472       0.50   12/24/14     1  
C. Schleuning (Series A)   7/8/09     167,500       0.50   01/08/15     1  
Series B   9/4/09     500,000       0.68   9/4/14     1  
Series C   8/20/09 – 8/26/09     4,634,886       0.55   2/20/15     1  
Series E   9/21/09     714,286       1.75   8/12/14     1  
Series F   10/6/11     12,000,000       0.40   10/6/14     1  
Series G   10/6/11     666,667       0.40   8/12/14     1  
Series H   1/26/12     12,000,000       0.50   8/1/15     1  
Series Q   6/21/12     12,000,000       0.50   12/22/15     1  
Series L   4/18/07     250,000       0.75   4/17/14     2  
                               
Series L (repriced)   4/18/07     1,000,000       0.34   4/17/13     2  
                               
Series M (modified)   4/18/07     6,000,000       0.34   7/31/14     2  
Series P   2/10/12     5,900,000       0.45   3/6/17     2  
                               
Private Investors   5/30/03- 6/30/09     8,609,375       0.47 – 1.25       5/30/13 - 7/18/14     3  
                               
Warrants held by Officer and Director   6/24/09- 7/6/09     3,497,539       0.40 – 0.50   12/24/14 – 1/6/15     4  
Consultants   5/22/03 – 3/6/12     937,500       0.28 – 2.00   5/22/13 - 3/5/17     5  
Derivative Liabilities

See below for details of the balances of derivative instruments at June 30, 2012 and September 30, 2011.

 

 

   

June 30,

2012

    

September 30,

2011

  
Series K warrants   $  -     $ 69,552  
 2009 financings warrants (Series A through E)     1,060,509       1,375,458  
 2008 warrants reclassified from equity to derivative liabilities on October 1, 2009 (Series N)     985,665       817,063  
 Series F & G warrants     2,026,667       -  
 Series Hwarrants     2,280,000       -  
 SeriesQ warrants     2,400,000          
 Convertible notes issued in settlement     -       4,999,000  
 Total derivative liabilities   $ 8,752,841     $ 7,261,073